Cancer Grand Challenges
Supports large interdisciplinary global teams tackling transformative unsolved problems in cancer biology.
Cancer Grand Challenges is a co-funded program of the National Cancer Institute and Cancer Research UK that supports large, interdisciplinary global research teams assembled to tackle the hardest unsolved problems in cancer biology. Launched in 2020, the program has run rounds in 2021 and 2023. Each winning team receives approximately $25 million over five years through an NIH Other Transaction Aw…
NCI-defined Grand Challenge topics in cancer biology — cross-cutting, high-risk, potentially transformative research that no single team could tackle alone.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NCI
All grants from this funder →Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge — Track 1
🇺🇸NCI · United States
Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.
NCI SBIR/STTR Omnibus (Next Receipt 5)
🇺🇸NCI · United States
Supports small businesses developing cancer technologies through national NIH collaboration pathways.
NCI Bioengineering Research Grants (BRG)
🇺🇸NCI · United States
Supports bioengineering teams tackling cancer by connecting life and physical science groups.
NCI IMAT R61 & R33
🇺🇸NCI · United States
Supports translational cancer technology from concept proof to advanced development through NCI.
NCI Small Grants Program — R03
🇺🇸NCI · United States
Supports cancer pilot research with broad domestic and international eligibility.
Similar grants
Browse the directory →
NHS Cancer Programme — Innovation Call 4
🇬🇧SBRI Healthcare · United Kingdom
Contracts UK or EU organisations to implement and independently evaluate mature cancer innovations across NHS sites in England.
DRIVe EZ-BAA Plus Phase (Advanced Development)
🇺🇸BARDA · United States
Funds United States health-security projects transitioning into advanced development after initial defense innovation stages.
BARDA Accelerator Network — Proof-of-Concept Funding
🇺🇸BARDA · United States
Supports United States health-security teams with early milestone-based funding for proof-of-concept countermeasure work.
DARPA ERIS (Expedited Research Implementation Series)
🇺🇸DARPA · United States
Backs research teams and institutions for DARPA ERIS in defense innovation, biotechnology, and medical technology.
BARDA BAA (through
🇺🇸BARDA · United States
Supports teams developing countermeasure technologies for CBRN, diagnostics, and readiness-focused therapeutics through BARDA BAA.
BARDA DRIVe ImmuneChip+ (through
🇺🇸BARDA · United States
Supports creators of immune-enabled organ-on-chip systems and biosensing manufacturing for critical health technology challenges.